Literature DB >> 28556415

Symptoms associated with Lewy body disease in mild cognitive impairment.

Paul C Donaghy1, Nicola Barnett1, Kirsty Olsen1, John-Paul Taylor1, Ian G McKeith1, John T O'Brien2, Alan J Thomas1.   

Abstract

OBJECTIVE: Dementia with Lewy bodies (DLB) is associated with a range of cognitive and non-cognitive symptoms. We aimed to identify if some of these symptoms might aid early diagnosis of Lewy body disease in cases of mild cognitive impairment (MCI).
METHODS: Lewy body MCI (MCI-LB; n = 36), Alzheimer's disease MCI (MCI-AD; n = 21), DLB (n = 36), AD (n = 21) and control (n = 20) participants were recruited. An interview-based questionnaire about the presence of symptoms thought to be associated with Lewy body disease was completed by participants with, where possible, their carer/relative. The prevalence of each symptom was compared between MCI-LB and MCI-AD and between established DLB and AD, and a symptom scale based on these findings was devised.
RESULTS: Fluctuating concentration/attention; episodes of confusion; muscle rigidity; changes in hand-writing, gait and posture; falls; drooling; weak voice; symptoms of REM sleep behaviour disorder (RBD) and misjudging objects were more common in MCI-LB compared with MCI-AD, and also in DLB compared with AD. Hyposmia, tremor, slowness and autonomic symptoms were not specific to Lewy body disease. REM sleep behaviour disorder and hyposmia were reported to develop several years prior to the onset of cognitive symptoms in Lewy body disease. A 10-point symptom scale differentiated between MCI-LB and MCI-AD with a sensitivity of 83% and a specificity of 100%.
CONCLUSIONS: Drooling, misjudging objects and symptoms related to parkinsonism, fluctuating cognition and RBD may be the most characteristic symptoms of MCI-LB. Slowness, tremor, autonomic symptoms and hyposmia are all common in MCI-LB but are not specific to the disease.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Lewy; dementia; mild cognitive impairment; prodromal; symptom

Mesh:

Year:  2017        PMID: 28556415     DOI: 10.1002/gps.4742

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

2.  Clinical Manifestations of Early-Onset Dementia With Lewy Bodies Compared With Late-Onset Dementia With Lewy Bodies and Early-Onset Alzheimer Disease.

Authors:  Jingwei Sim; Huihua Li; Shahul Hameed; Simon Kang Seng Ting
Journal:  JAMA Neurol       Date:  2022-07-01       Impact factor: 29.907

3.  Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions.

Authors:  Masahito Yamada; Junji Komatsu; Keiko Nakamura; Kenji Sakai; Miharu Samuraki-Yokohama; Kenichi Nakajima; Mitsuhiro Yoshita
Journal:  J Mov Disord       Date:  2019-11-08

4.  Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodies.

Authors:  Calum A Hamilton; James Frith; Paul C Donaghy; Sally A H Barker; Rory Durcan; Sarah Lawley; Nicola Barnett; Michael Firbank; Gemma Roberts; John-Paul Taylor; Louise M Allan; John O'Brien; Alison J Yarnall; Alan J Thomas
Journal:  Int J Geriatr Psychiatry       Date:  2022-04       Impact factor: 3.850

5.  Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD).

Authors:  James E Galvin; Stephanie Chrisphonte; Iris Cohen; Keri K Greenfield; Michael J Kleiman; Claudia Moore; Mary Lou Riccio; Amie Rosenfeld; Niurka Shkolnik; Marcia Walker; Lun-Ching Chang; Magdalena I Tolea
Journal:  Alzheimers Dement       Date:  2021-04-01       Impact factor: 21.566

6.  Automated analysis of facial emotions in subjects with cognitive impairment.

Authors:  Zifan Jiang; Salman Seyedi; Rafi U Haque; Alvince L Pongos; Kayci L Vickers; Cecelia M Manzanares; James J Lah; Allan I Levey; Gari D Clifford
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.